Lisa Olson is the founder of Enthera. Enthera has raised $35M in total funding. Latest round: Series A. Backed by Sofinnova Partners, AbbVie, JDRF T1D Fund.
Lisa M. Olson, Ph.D., is the Chief Executive Officer of Enthera Pharmaceuticals, a clinical-stage biotech company focused on restorative therapies for Type 1 diabetes and inflammatory bowel disease. She was appointed CEO in January 2024, having previously served on the company's Scientific Advisory Board since December 2020. Olson is based in the Greater Boston area while leading the Milan-headquartered firm.
Full founder directory · Investor directory · Company funding database · Fundraising library